TP53 and central nervous system cancer: This TP53 target is capable of prolonging cancer cell survival through the activation of oxidative phosphorylation in cancer cells which ultimately results in a delay in glucose depletion [28]; the fold regulation of the TP53 gene was observed to be significantly higher in the plasma samples of patients with glioma.